Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol-Myers Squibb (NY: BMY ) 44.85 +0.15 (+0.34%) Official Closing Price Updated: 7:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 21,281,968 Open 44.68 Bid (Size) 44.80 (1) Ask (Size) 44.90 (1) Prev. Close 44.70 Today's Range 44.34 - 45.37 52wk Range 44.34 - 69.10 Shares Outstanding 2,222,113,553 Dividend Yield 5.08% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights April 26, 2024 Via Benzinga Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review April 26, 2024 Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. Via Investor's Business Daily Performance YTD -14.99% -14.99% 1 Month -17.30% -17.30% 3 Month -10.07% -10.07% 6 Month -12.49% -12.49% 1 Year -32.83% -32.83% More News Read More CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma April 26, 2024 From Bristol Myers Squibb Via Business Wire Why Bristol Myers Squibb Stock Is Sinking Today April 25, 2024 Via The Motley Fool A Closer Look at Bristol-Myers Squibb's Options Market Dynamics April 19, 2024 Via Benzinga Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points April 26, 2024 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results April 25, 2024 Via Benzinga Exposures Fossil Fuels Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions April 25, 2024 Via Benzinga PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal April 25, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024 April 25, 2024 Via InvestorPlace Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 25, 2024 Via Benzinga Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts April 25, 2024 Via InvestorPlace Topics Workforce Exposures Layoff Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript April 25, 2024 Via The Motley Fool Topics Earnings Exposures Financial Is Bristol Myers Squibb Stock a Millionaire Maker? April 25, 2024 Via The Motley Fool Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market April 25, 2024 Via Investor's Business Daily AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags April 25, 2024 Via Investor's Business Daily Bristol Myers Squibb Reports First Quarter Financial Results for 2024 April 25, 2024 From Bristol Myers Squibb Via Business Wire Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook April 23, 2024 Via Benzinga US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst April 25, 2024 Via Benzinga 5 Crash-Proof Stocks to Buy Immediately April 22, 2024 Via InvestorPlace Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster April 22, 2024 From Bristol Myers Squibb Via Business Wire 3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations April 20, 2024 Via The Motley Fool These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? April 19, 2024 Via InvestorPlace Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week April 21, 2024 Via Benzinga FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies April 19, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.